Kelly Thomas Patrick 4
4 · Deciphera Pharmaceuticals, Inc. · Filed Jan 18, 2024
Insider Transaction Report
Form 4
Kelly Thomas Patrick
Chief Financial Officer
Transactions
- Sale
Common Stock
2024-01-16$14.47/sh−2,435$35,234→ 66,085 total
Footnotes (1)
- [F1]This sale was to cover tax liabilities in the vesting of restricted stock units.